Millennium Management
EIGR

Millennium Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Millennium Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-279
Closed -$2.38M – 3959
2015
Q1 		$2.38M Buy
+279
New +$2.44M ﹤0.01% 1846

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Millennium Management's EIGR Position: Q1 2024 in Review

Millennium Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 2,705 shares — an estimated $18.2K sold.

Millennium Management first reported a position in EIGR in Q2 2014 and held it in 20 quarters. The position peaked at $16.8M in Q1 2015. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Millennium Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 2,705 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $18.2K.
  • Millennium Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2014 and held it in 20 quarters.
  • Millennium Management's Eiger BioPharmaceuticals, Inc. position peaked at $16.8M in Q1 2015.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.